Advertisement

The Diagnosis of Sarcoidosis

  • Marc A. JudsonEmail author
Chapter
Part of the Respiratory Medicine book series (RM, volume 17)

Abstract

The diagnosis of sarcoidosis is never completely secure. The diagnosis can, rarely, be made on clinical grounds without biopsy confirmation if the clinical presentation is very specific for the disease. Otherwise, histological confirmation of granulomatous inflammation is required. However, identification of granulomatous inflammation is inadequate to make the diagnosis of sarcoidosis as this histological pattern is associated with many alternative diseases. Therefore, a diligent effort must be undertaken to exclude such diseases. This effort includes obtaining a detailed medical history as well as careful examination of the biopsied material. Because sarcoidosis is a multisystem granulomatous disease of unknown cause, additional efforts must be made to identify involvement in at least two organs to confirm the diagnosis. This chapter outlines the approach and potential pitfalls in establishing a diagnosis of sarcoidosis.

Keywords

Sarcoidosis Diagnosis Etiology Biopsy Pathology 

References

  1. 1.
    Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149–73.PubMedGoogle Scholar
  2. 2.
    Judson MA. The diagnosis of sarcoidosis. Clin Chest Med. 2008;29:415–27, viii.Google Scholar
  3. 3.
    Hosoda Y, Yamaguchi M, Hiraga Y. Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? Clin Chest Med. 1997;18:681–94.PubMedCrossRefGoogle Scholar
  4. 4.
    Rybicki BA, Major M, Popovich Jr J, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–41.PubMedCrossRefGoogle Scholar
  5. 5.
    Siltzbach LE, Fishman AP, editors. Sarcoidosis. New York: McGraw-Hill; 1980.Google Scholar
  6. 6.
    Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol. 1974;99:250–7.PubMedGoogle Scholar
  7. 7.
    Reich JM, Brouns MC, O’Connor EA, et al. Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest. 1998;113:147–53.PubMedCrossRefGoogle Scholar
  8. 8.
    Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164:2085–91.PubMedCrossRefGoogle Scholar
  9. 9.
    Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–30.PubMedCrossRefGoogle Scholar
  10. 10.
    Prezant DJ, Dhala A, Goldstein A, et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest. 1999;116:1183–93.PubMedCrossRefGoogle Scholar
  11. 11.
    Edwards LB, Acquaviva FA, Livesay VT, et al. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis. 1969;99(Suppl):1–132.PubMedGoogle Scholar
  12. 12.
    Harris KM, McConnochie K, Adams H. The computed tomographic appearances in chronic berylliosis. Clin Radiol. 1993;47:26–31.PubMedCrossRefGoogle Scholar
  13. 13.
    Newman LS, Kreiss K, King Jr TE, et al. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis. 1989;139:1479–86.PubMedCrossRefGoogle Scholar
  14. 14.
    Mukhopadhyay S, Gal AA. Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med. 2010;134:667–90.PubMedGoogle Scholar
  15. 15.
    Muller-Quernheim J, Gaede KI, Fireman E, et al. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J. 2006;27:1190–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Kreiss K, Day GA, Schuler CR. Beryllium: a modern industrial hazard. Annu Rev Public Health. 2007;28:259–77.PubMedCrossRefGoogle Scholar
  17. 17.
    Taylor TP, Ding M, Ehler DS, et al. Beryllium in the environment: a review. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2003;38:439–69.PubMedCrossRefGoogle Scholar
  18. 18.
    Newman LS, Kreiss K. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium. Am Rev Respir Dis. 1992;145:1212–4.PubMedCrossRefGoogle Scholar
  19. 19.
    Yi ES. Hypersensitivity pneumonitis. Crit Rev Clin Lab Sci. 2002;39:581–629.PubMedCrossRefGoogle Scholar
  20. 20.
    Glazer CS, Martyny JW, Lee B, et al. Nontuberculous mycobacteria in aerosol droplets and bulk water samples from therapy pools and hot tubs. J Occup Environ Hyg. 2007;4:831–40.PubMedCrossRefGoogle Scholar
  21. 21.
    Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Winterbauer RH, Belic N, Moores KD. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med. 1973;78:65–71.PubMedCrossRefGoogle Scholar
  23. 23.
    Freiman DB, Miller WT. Sarcoidosis: a multisystem disease. Am Fam Physician. 1977;15:78–82.PubMedGoogle Scholar
  24. 24.
    Nishino M, Lee KS, Itoh H, et al. The spectrum of pulmonary sarcoidosis: variations of high-resolution CT findings and clues for specific diagnosis. Eur J Radiol. 2010;73:66–73.PubMedCrossRefGoogle Scholar
  25. 25.
    Oberstein A, von Zitzewitz H, Schweden F, et al. Non invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14:65–72.PubMedGoogle Scholar
  26. 26.
    Leung AN, Brauner MW, Caillat-Vigneron N, et al. Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay. J Comput Assist Tomogr. 1998;22:229–34.PubMedCrossRefGoogle Scholar
  27. 27.
    Criado E, Sanchez M, Ramirez J, et al. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics. 2010;30:1567–86.PubMedCrossRefGoogle Scholar
  28. 28.
    Hamper UM, Fishman EK, Khouri NF, et al. Typical and atypical CT manifestations of pulmonary sarcoidosis. J Comput Assist Tomogr. 1986;10:928–36.PubMedCrossRefGoogle Scholar
  29. 29.
    Muller NL, Kullnig P, Miller RR. The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol. 1989;152:1179–82.PubMedCrossRefGoogle Scholar
  30. 30.
    Dawson WB, Muller NL. High-resolution computed tomography in pulmonary sarcoidosis. Semin Ultrasound CT MR. 1990;11:423–9.PubMedGoogle Scholar
  31. 31.
    Sheffield EA. Pathology of sarcoidosis. Clin Chest Med. 1997;18:741–54.PubMedCrossRefGoogle Scholar
  32. 32.
    O’Regan A, Berman JS. Sarcoidosis. Ann Intern Med. 2012;156:ITC5-1, ITC5-2, ITC5-3, ITC5-4, ITC5-5, ITC5-6, ITC5-7, ITC5-8, ITC5-9, ITC5-10, ITC15-11, ITC15-12, ITC15-13, ITC15-14, ITC15-15; quiz ITC15-16.Google Scholar
  33. 33.
    Bunting PS, Szalai JP, Katic M. Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis. Clin Biochem. 1987;20:213–9.PubMedCrossRefGoogle Scholar
  34. 34.
    De Smet D, Martens GA, Berghe BV, et al. Use of likelihood ratios improves interpretation of laboratory testing for pulmonary sarcoidosis. Am J Clin Pathol. 2010;134:939–47.PubMedCrossRefGoogle Scholar
  35. 35.
    Teirstein AS, Judson MA, Baughman RP, et al. The spectrum of biopsy sites for the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22:139–46.PubMedGoogle Scholar
  36. 36.
    Lynch 3rd JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med. 1997;18: 755–85.PubMedCrossRefGoogle Scholar
  37. 37.
    Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis. 1980;122:721–4.PubMedGoogle Scholar
  38. 38.
    Koonitz CH, Joyner LR, Nelson RA. Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann Intern Med. 1976;85:64–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Koerner SK, Sakowitz AJ, Appelman RI, et al. Transbronchinal lung biopsy for the diagnosis of sarcoidosis. N Engl J Med. 1975;293:268–70.PubMedCrossRefGoogle Scholar
  40. 40.
    Mitchell DM, Mitchell DN, Collins JV, et al. Transbronchial lung biopsy through fibreoptic bronchoscope in diagnosis of sarcoidosis. Br Med J. 1980;280:679–81.PubMedCrossRefGoogle Scholar
  41. 41.
    Poe RH, Israel RH, Utell MJ, et al. Probability of a positive transbronchial lung biopsy result in sarcoidosis. Arch Intern Med. 1979;139:761–3.PubMedCrossRefGoogle Scholar
  42. 42.
    Roethe RA, Fuller PB, Byrd RB, et al. Transbronchoscopic lung biopsy in sarcoidosis. Optimal number and sites for diagnosis. Chest. 1980;77:400–2.PubMedCrossRefGoogle Scholar
  43. 43.
    Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial biopsy for sarcoidosis: a prospective study. Chest. 2001;120:109–14.PubMedCrossRefGoogle Scholar
  44. 44.
    Agarwal R, Srinivasan A, Aggarwal AN, et al. Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med. 2012;106:883–92.PubMedCrossRefGoogle Scholar
  45. 45.
    Tremblay A, Stather DR, Maceachern P, et al. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest. 2009;136:340–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Nagai S, Izumi T. Bronchoalveolar lavage. Still useful in diagnosing sarcoidosis? Clin Chest Med. 1997;18:787–97.PubMedCrossRefGoogle Scholar
  47. 47.
    Costabel U, Guzman J, Albera C, et al. Bronchoalveolar lavage in sarcoidosis. In: Baughman RP, editor. Lung biology in health and disease; sarcoidosis. New York: Informa; 2006. p. 399–414.Google Scholar
  48. 48.
    Winterbauer RH, Lammert J, Selland M, et al. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest. 1993;104:352–61.PubMedCrossRefGoogle Scholar
  49. 49.
    Costabel U, Zeiss AW, Guzman J. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis. 1992;9:211–4.Google Scholar
  50. 50.
    Stern BJ, Krumholz A, Johns C, et al. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909–17.PubMedCrossRefGoogle Scholar
  51. 51.
    Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299–302.PubMedCrossRefGoogle Scholar
  52. 52.
    Teirstein AS, Machac J, Almeida O, et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007;132:1949–53.PubMedCrossRefGoogle Scholar
  53. 53.
    Sulavik SB, Palestro CJ, Spencer RP, et al. Extrapulmonary sites of radiogallium accumulation in sarcoidosis. Clin Nucl Med. 1990;15:876–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Chung YM, Lin YC, Huang DF, et al. Conjunctival biopsy in sarcoidosis. J Chin Med Assoc. 2006;69:472–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Khan F, Wessely Z, Chazin SR, et al. Conjunctival biopsy in sarcoidosis: a simple, safe, and specific diagnostic procedure. Ann Ophthalmol. 1977;9:671–6.PubMedGoogle Scholar
  56. 56.
    Nichols CW, Eagle Jr RC, Yanoff M, et al. Conjunctival biopsy as an aid in the evaluation of the patient with suspected sarcoidosis. Ophthalmology. 1980;87:287–91.PubMedGoogle Scholar
  57. 57.
    Leavitt JA, Campbell RJ. Cost-effectiveness in the diagnosis of sarcoidosis: the conjunctival biopsy. Eye (Lond). 1998;12(Pt 6):959–62.CrossRefGoogle Scholar
  58. 58.
    Spaide RF, Ward DL. Conjunctival biopsy in the diagnosis of sarcoidosis. Br J Ophthalmol. 1990;74:469–71.PubMedCrossRefGoogle Scholar
  59. 59.
    Bornstein JS, Frank MI, Radner DB. Conjunctival biopsy in the diagnosis of sarcoidosis. N Engl J Med. 1962;267:60–4.PubMedCrossRefGoogle Scholar
  60. 60.
    Crick R, Hoyle C, Mather G. Conjunctival biopsy in sarcoidosis. Br Med J. 1955;2:1180–1.PubMedCrossRefGoogle Scholar
  61. 61.
    Wertheim MS, Mathers WD, Suhler EB, et al. Histopathological features of conjunctival sarcoid nodules using noninvasive in vivo confocal microscopy. Arch Ophthalmol. 2005;123: 274–6.PubMedCrossRefGoogle Scholar
  62. 62.
    Lehmuskallio E, Hannuksela M, Halme H. The liver in sarcoidosis. Acta Med Scand. 1977;202:289–93.PubMedCrossRefGoogle Scholar
  63. 63.
    Hercules HD, Bethlem NM. Value of liver biopsy in sarcoidosis. Arch Pathol Lab Med. 1984;108:831–4.PubMedGoogle Scholar
  64. 64.
    Bilir M, Mert A, Ozaras R, et al. Hepatic sarcoidosis: clinicopathologic features in thirty-seven patients. J Clin Gastroenterol. 2000;31:337–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Andonopoulos AP, Papadimitriou C, Melachrinou M, et al. Asymptomatic gastrocnemius muscle biopsy: an extremely sensitive and specific test in the pathologic confirmation of sarcoidosis presenting with hilar adenopathy. Clin Exp Rheumatol. 2001;19:569–72.PubMedGoogle Scholar
  66. 66.
    Truedson H, Stjernberg N, Thunell M. Scalene lymph node biopsy. A diagnostic method in sarcoidosis. Acta Chir Scand. 1985;151:121–3.PubMedGoogle Scholar
  67. 67.
    Siltzbach LE. The Kveim test in sarcoidosis. A study of 750 patients. JAMA. 1961;178:476–82.PubMedCrossRefGoogle Scholar
  68. 68.
    Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med. 2007;28:36–52.PubMedCrossRefGoogle Scholar
  69. 69.
    Adams DO. The biology of the granuloma. In: Ioachim HL, editor. Pathology of granulomas. New York: Raven; 1983. p. 1–20.Google Scholar
  70. 70.
    Israel HL, Goldstein RA. Hepatic granulomatosis and sarcoidosis. Ann Intern Med. 1973;79:669–78.PubMedCrossRefGoogle Scholar
  71. 71.
    Merrill PT, Kim J, Cox TA, et al. Uveitis in the southeastern United States. Curr Eye Res. 1997;16:865–74.PubMedCrossRefGoogle Scholar
  72. 72.
    Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:75–86.PubMedGoogle Scholar
  73. 73.
    Manouvrier-Hanu S, Puech B, Piette F, et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature. Am J Med Genet. 1998;76:217–21.PubMedCrossRefGoogle Scholar
  74. 74.
    Kurokawa T, Kikuchi T, Ohta K, et al. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology. 2003;110:2040–4.PubMedCrossRefGoogle Scholar
  75. 75.
    Brinker H. Granulomatous lesions of unknown significance: the GLUS syndrome. In: James DG, editor. Sarcoidosis and other granulomatous disorders. Philadelphia: W.B. Saunders; 1994. p. 69–86.Google Scholar
  76. 76.
    Churg A, Carrington CB, Gupta R. Necrotizing sarcoid granulomatosis. Chest. 1979;76:406–13.PubMedCrossRefGoogle Scholar
  77. 77.
    Quaden C, Tillie-Leblond I, Delobbe A, et al. Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations. Eur Respir J. 2005;26:778–85.PubMedCrossRefGoogle Scholar
  78. 78.
    Lazzarini LC, de Fatima do Amparo Teixeira M, Souza Rodrigues R, et al. Necrotizing sarcoid granulomatosis in a family of patients with sarcoidosis reinforces the association between both entities. Respiration. 2008;76:356–60.PubMedCrossRefGoogle Scholar
  79. 79.
    Rossman MD, Thompson B, Frederick M, et al. HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:125–32.PubMedGoogle Scholar
  80. 80.
    Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med. 2011;183:573–81.PubMedCrossRefGoogle Scholar
  81. 81.
    Martinetti M, Luisetti M, Cuccia M. HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:83–95.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care Medicine, Department of MedicineAlbany Medical CollegeAlbanyUSA

Personalised recommendations